Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia - A possible pathogenesis of necrobiotic xanthogranuloma

Atherosclerosis

Volumn 142, Issue 2, 1999, Pages 355-365

  Matsuura, Fumihiko ^a   Yamashita, Shizuya ^a   Hirano, Ken ichi ^a   Ishigami, Masato ^a   Hiraoka, Hisatoyo ^a   Tamura, Ritsu ^a   Nakagawa, Tsutomu ^a   Nishida, Makoto ^a   Sakai, Naohiko ^a   Nakamura, Tadashi ^a   Nozaki, Shuichi ^a   Funahashi, Tohru ^a   Matsumoto, Chiho ^a   Higashiyama, Mari ^a   Yoshikawa, Kunihiko ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Atherosclerosis; Complement; Low density lipoprotein; Macrophage colony stimulating factor; Monocyte; Necrobiotic xanthogranuloma

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; MONOCYTE; MOUSE; NECROBIOTIC DISORDER; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; XANTHOGRANULOMA;

EID: 0032936019     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00260-3     Document Type: Article

References (29)

1. Kossard S., Winkelmann R.K. Necrobiotic xanthogranuloma with paraproteinemia. J. Am. Acad. Dermatol. 3:1980;257-270.
2. Scupham R.K., Fretzin D.F. Necrobiotic xanthogranuloma with paraproteinemia. Arch. Pathol. Lab. Med. 113:1989;1389-1391.
3. David A.M., Winkelmann R.K. Necrobiotic xanthogranuloma. Arch. Dermatol. 128:1992;94-100.
4. Napoli C., Postiglione A., Triggiani M. et al. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Atherosclerosis. 118:1995;259-273.
5. Winkelmann R.K., Mcevoy M.T. Diffuse-plane normolipaemic xanthoma with aortic valve xanthoma. Clin. Exp. Dermatol. 16:1991;38-40.
6. Plotnick H., Taniguchi Y., Hashimoto K. et al. Periorbital necrobiotic xanthogranuloma and stage 1 multiple myeloma. Am. Acad. Dermatol. 25:1991;373-377.
7. Peng H.B., Rajavashisth T.B., Libby P. et al. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270:1995;17050-17055.
8. Bratzler R.L., Chisolm G.M., Cotton C.K. et al. The distribution of labelled low density lipoprotein across the rabbit thoracic aorta in vivo. Atherosclerosis. 28:1977;289-307.
9. Lopes-Virella M.F., Griffith R.L. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low-density lipoprotein antibody. Artheroscler. Thromb. 11:1991;1356-1367.
10. Bilheimer D.W., Steinberg D., Levy R.I. The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observation. Biochim. Biophys. Acta. 260:1972;212-221.
11. Andoh A., Fujiyama Y., Kitoh K. Macrophage colony-stimulating factor (M-CSF) enhances complement C3 production by monocytes/macrophages. Int. J. Hematol. 57:1993;53-59.
12. Goldstein J.L., Ho Y.K., Brown M.S. et al. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine ß-very low density lipoproteins. J. Biol. Chem. 225:1980;1839-1848.
13. Hara A., Radin N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 90:1980;420-426.
14. Heider J.G., Boyett R.L. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19:1978;514-518.
15. Lowry O.H., Rosebrough N.J., Farr A.L. et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
16. Goldstein J.L., Brown M.S., Stone N.J. Genetics of the LDL receptor; evidence that the mutations affecting binding and internalization are alleic. Cell. 12:1977;629-641.
17. Nakagawa T., Ueyama Y., Nozaki S. et al. Marked hypocholesterolemia in a case with adrenal adenoma; enhanced catabolism of low density lipoprotein (LDL) via the receptor of tumor cells. J. Clin. Endocrinol. Metab. 80:1995;92-96.
18. Miyazaki A., Rahim A.T.M.A., Ohta T. et al. High density lipoprotein mediates selective reduction in cholesterol esters from macrophage foam cells. Biochim. Biophys. Acta. 1126:1992;73-80.
19. Piha M., Lindstedt L., Kovanen P.T. Fusion of proteolyzed low density lipoprotein in the fluid phase; a novel mechanism generating atherogenic lipoprotein particles. Biochemistry. 34:1995;10210-10219.
20. Nozaki S., Kashiwagi H., Yamashita S. et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96:1995;1859-1865.
21. Giry C., Giroux L.M., Roy M. et al. Characterization of inherited scavenger receptor overexpression and abnormal macrophage phenotype in a normolipidemic subject with planar xanthoma. J. Lipid. Res. 37:1996;1422-1435.
22. Shimomura I., Shimano H., Horton J.D. et al. Differential expression of exon 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 99:1997;838-845.
23. O'Driscoll L., Daly C., Saleh M. et al. The use of reverse transcriptase polymerase chain reaction (RT-PCR) to investigate specific gene expression multidrug-resistant cells. Cytotechnology. 12:1993;289-314.
24. Shimomura I., Funahashi T., Takahashi M. et al. Enhanced expression of PAI-1 in visceral fat; possible contributor to vascular disease in obesity. Nature Med. 2:1996;800-803.
25. Hanamura T., Motoyoshi K., Yoshida K. et al. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood. 72:1988;886-892.
26. Ralph P. Phenotypic characteristics of monocytes and their developmental stages; colony stimulating factors. Zembala M., Asherson G.L. Human Monocytes. 1989;227-246 Academic Press, San Diego.
27. Shimano H., Yamada N., Ishibashi S. et al. Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and independent pathway in rabbits. J. Biol. Chem. 65:1990;12869-12875.
28. Sim R.B., Sim E. Biochemistry and cell biology of monocytes; complemental components. Zembala M., Asherson G.L. Human Monocytes. 1989;261-271 Academic press, San Diego.
29. Klimov A.N., Denisenko A.D., Popov A.V. et al. Lipoprotein-antibody immune complexes-Their catabolism and role in foam cell formation. Atherosclerosis. 58:1985;1-15.